Cargando…

Cytokine release syndrome and associated neurotoxicity in cancer immunotherapy

A paradigm shift has recently occurred in the field of cancer therapeutics. Traditional anticancer agents, such as chemotherapy, radiotherapy and small-molecule drugs targeting specific signalling pathways, have been joined by cellular immunotherapies based on T cell engineering. The rapid adoption...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morris, Emma C., Neelapu, Sattva S., Giavridis, Theodoros, Sadelain, Michel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127450/ https://www.ncbi.nlm.nih.gov/pubmed/34002066 http://dx.doi.org/10.1038/s41577-021-00547-6

Ejemplares similares

Biomarkers of cytokine release syndrome and neurotoxicity related to CAR-T cell therapy
por: Wang, Zhenguang, et al.
Publicado: (2018)

Interleukin Inhibitors in Cytokine Release Syndrome and Neurotoxicity Secondary to CAR-T Therapy
por: Ferreros, Puri, et al.
Publicado: (2022)

Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies
por: Xiao, Xinyi, et al.
Publicado: (2021)

Targeting the A(3) adenosine receptor to treat cytokine release syndrome in cancer immunotherapy
por: Cohen, Shira, et al.
Publicado: (2019)

Editorial: Understanding the Cytokine Release Syndrome: Toward Improving Cancer Immunotherapy
por: Martín-Antonio, Beatriz
Publicado: (2021)

Cytokine release syndrome and cancer immunotherapies – historical challenges and promising futures
por: Shah, Deep, et al.
Publicado: (2023)

Versatile CAR T-cells for cancer immunotherapy
por: Chu, Fuliang, et al.
Publicado: (2018)

Cytokine Release Syndrome in the Immunotherapy of Hematological Malignancies: The Biology behind and Possible Clinical Consequences
por: Tvedt, Tor Henrik Anderson, et al.
Publicado: (2021)

Cytokine release syndrome
por: Shimabukuro-Vornhagen, Alexander, et al.
Publicado: (2018)

Neurotoxicity of novel cancer immunotherapies
por: Willis, M. D., et al.
Publicado: (2019)

Anti-PD-1 antibodies for the treatment of B-cell lymphoma: Importance of PD-1(+) T-cell subsets
por: Chu, Fuliang, et al.
Publicado: (2014)

CXCR5+CD8+ T cells are localized in B cell follicles and germinal centers and exhibit regulatory and anti-tumor function
por: Chu, Fuliang, et al.
Publicado: (2015)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
por: Śliwa-Tytko, Patrycja, et al.
Publicado: (2022)

Immunotherapy Associated Neurotoxicity in Pediatric Oncology
por: Shalabi, Haneen, et al.
Publicado: (2022)

Cytokines in Cancer Immunotherapy
por: Lee, Sylvia, et al.
Publicado: (2011)

Cytokines in CAR T Cell–Associated Neurotoxicity
por: Gust, Juliane, et al.
Publicado: (2020)

Therapeutic Vaccine for Lymphoma
por: Lee, Seung-Tae, et al.
Publicado: (2007)

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma
por: Neelapu, Sattva S, et al.
Publicado: (2020)

Cytokine Release Syndrome: Current Perspectives
por: Murthy, Hemant, et al.
Publicado: (2019)

Therapy of newly diagnosed follicular lymphoma
por: Westin, Jason R., et al.
Publicado: (2012)

Neurotoxicity and Cytokine Release Syndrome After Chimeric Antigen Receptor T Cell Therapy: Insights Into Mechanisms and Novel Therapies
por: Siegler, Elizabeth L., et al.
Publicado: (2020)

Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention
por: Zhang, Benxia, et al.
Publicado: (2022)

Editorial: CAR T-Cell Therapies in Hematologic Tumors
por: Coscia, Marta, et al.
Publicado: (2020)

Cytokines in clinical cancer immunotherapy
por: Berraondo, Pedro, et al.
Publicado: (2018)

Cytokine Release Syndrome Grade as a Predictive Marker for Infections in Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Treated With Chimeric Antigen Receptor T Cells
por: Park, Jae H, et al.
Publicado: (2018)

COVID-19 Vaccine-Related Axillary and Cervical Lymphadenopathy in Patients with Current or Prior Breast Cancer and Other Malignancies: Cross-Sectional Imaging Findings on MRI, CT, and PET-CT
por: Lane, Deanna L, et al.
Publicado: (2021)

Clinical Application of Cytokines in Cancer Immunotherapy
por: Qiu, Yi, et al.
Publicado: (2021)

Continuous renal replacement therapy in cytokine release syndrome following immunotherapy or cellular therapies?
por: Constantinescu, Catalin, et al.
Publicado: (2020)

Grading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
por: Porter, David, et al.
Publicado: (2018)

A review of neurotoxicities associated with immunotherapy and a framework for evaluation
por: Burton, Leeann B, et al.
Publicado: (2021)

Evaluation and management of acute high-grade immunotherapy-related neurotoxicity
por: Sandoval, Marcelo, et al.
Publicado: (2023)

Next-generation cytokines for cancer immunotherapy
por: Xue, Diyuan, et al.
Publicado: (2021)

Neurotoxicity Associated With Cancer Therapy
por: Lu Lee, Eva, et al.
Publicado: (2012)

The Many Faces of Cytokine Release Syndrome-Related Coagulopathy
por: Wang, Jiasheng, et al.
Publicado: (2021)

Cytokine release syndrome: grading, modeling, and new therapy
por: Liu, Delong, et al.
Publicado: (2018)

IL-12 Family Cytokines in Cancer and Immunotherapy
por: Mirlekar, Bhalchandra, et al.
Publicado: (2021)

Senolytic CAR T cells reverse senescence-associated pathologies
por: Amor, Corina, et al.
Publicado: (2020)

Rituximab and Cytokine Release Syndrome
por: Kulkarni, Hrishikesh S., et al.
Publicado: (2012)

Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers
por: Barros, Marconi Rego, et al.
Publicado: (2018)

Use of human splenocytes in an innovative humanised mouse model for prediction of immunotherapy‐induced cytokine release syndrome
por: Matas‐Céspedes, Alba, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vutt3n5ttqeb20c5nana5l8rig